Classes of Compounds that Interact with Integrins
OwnerWim Meutermans, Michael L. West +3inventors
InventorsWim Meutermans, Michael L. West, Giang Thanh Le, Judy Halliday, Christopher Clark
Life of this patent
Estimating the term…
Loading patent…
OwnerWim Meutermans, Michael L. West +3inventors
InventorsWim Meutermans, Michael L. West, Giang Thanh Le, Judy Halliday, Christopher Clark
Estimating the term…
A method of inhibiting or effecting the activity of an integral receptor which comprises contacting an integrin with a compound of formula I, or a pharmaceutically acceptable salt thereof; General Formula I Wherein the ring may be of any configuration; Z is sulphur, oxygen, CH2, NH, NRA or hydrogen, in the case where Z is hydrogen then R1 is not present, RA is selected from the set defined for R1 to R5, X is oxygen or NRA providing that at least one X of General Formula I is NRA, X may also combine independently with one of R1 to R5 to form an azide, R1 to R5 are independently selected from the group comprising H, —(CO)R6 or an alkyl, acyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl substituent of 1 to 20 atoms, which is optionally substituted, and can be branched or linear wherein substituents may optionally be further substituted, wherein R6 is selected from the group comprising an alkyl, acyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl substituent of 1 to 20 atoms, which is optionally substituted, and can be branched or linear wherein substituents may optionally be further substituted, with the proviso that XR2 or XR3 or XR4 or XR5 is not NH2, with the further proviso that not more than one of R2 to R5 is hydrogen, where the group X is NRA and RA is not hydrogen, the groups RA and the corresponding group R2 to R5 may combine to form a cycle.
A method of inhibiting or effecting the activity of an integrin receptor which comprises contacting an integrin with an effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof;
6-7. (canceled)
A method of treatment of a disease or condition affected by integrin inhibition which comprises administering an effective amount of a compound of formula I,
A compound of formula VI:
19-20. (canceled)
A method of inhibiting or effecting the activity of an integrin receptor which comprises contacting an integrin with a compound of the formula:
Dependencies are inferred from the claim text.